Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : AMERICAN BIOMED, Minimally Invasive Technology (ABMI) -- Ignore unavailable to you. Want to Upgrade?

To: greg Benfield who wrote (2188)	11/23/1998 4:57:00 PM
From: kiwi	Respond to of 2887

Greg, I think that you are right in that most people are in the ‘know' about what is going on with American BioMed and that there is not a lot of point putting out a news release re the Summer's settlement. As no one seems to want to discuss their own feedback from the company I won't say too much on the subject either, except that I had a discussion with Steve Rash since I last posted and am confident that the company is moving in the right direction and is being competently managed with the interests of the shareholders at heart. Steve Rash is as frustrated as we are with the present price which is certainly not even close to being indicative of the true value of the company based on the value of the patents and potential products e.g. Omnifilter and OmniCath. It will not take a lot of positive news to shift the stock price from these current lows and I think this is reflected in the LaSalle release in September which moved the price to $0.50. The only specific comment I will make re my discussion with Steve Rash is that he doesn't think that the majority of news releases are cost effective, hence we are not hearing much. Of the three releases in September the only one to have any major effect on the stock price was the LaSalle announcement. I suggest that if any shareholders have strong viewpoints on this then they call Steve Rash themselves. Based on my discussions and observations I am confident that ABMI will perform for us and that it will only take one major release or the efforts of Stuart Bockler to make those that have sold this stock down for various reasons (be it tax loss or whatever) to reassess their positions. ABMI has the ability to bring it's development products to the market while at the same time being an excellent buyout proposition. When the potential is compared to the likes of AVEI and the progress it has made over the past 2 years, the question I ask is - Do we want a buyout at all? Kiwi